Canadian Journal of Cardiology

Left Ventricular Myocardial Dyssynchrony Is Already Present in Nondiabetic Patients With Metabolic Syndrome

Published:November 08, 2013DOI:


      The presence of left ventricular (LV) dyssynchrony in individuals with metabolic syndrome (MetS), a predictor of type 2 diabetes (T2D), lacks clarity. We compared LV dyssynchrony in MetS individuals with and without T2D, and healthy control subjects using speckle-tracking imaging echocardiography. Ninety-two MetS participants (64 without, 28 with T2D) and 40 control subjects underwent echocardiographic and clinical/biological analyses. LV-dyssynchrony in the longitudinal axis only was present in all MetS individuals, but was not further exacerbated by T2D. Strong associations were found with systemic inflammation, abdominal obesity, and LV mass. Investigations of myocardial dyssynchrony in the nondiabetic MetS stage might facilitate timely and more effective prevention.


      La présence de dyssynchronies ventriculaires gauches (VG) chez les individus ayant un syndrome métabolique (SM), un prédicteur du diabète de type 2 (DT2), est peu documentée. Nous avons comparé la dyssynchronie VG chez les individus ayant un SM associé ou non à un DT2, et des sujets témoins en bonne santé au moyen de l’échocardiographie avec « speckle-tracking ». Quatre-vingt-douze (92) participants ayant un SM (64 non associés au DT2, 28 associés au DT2) et 40 sujets témoins ont bénéficiés de bilans échocardiographiques, et cliniques/biologiques. La dyssynchronie VG dans l’axe longitudinal seul était présente chez tous les individus ayant un SM, mais n’était pas davantage exacerbée par le DT2. Nous avons observé des liens importants avec l’inflammation systémique, l’obésité abdominale et la masse VG. Les évaluations de la dyssynchronie myocardique au stade du SM non associé au diabète pourraient favoriser une prévention prompte et plus efficace.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Alberti K.G.
        • Eckel R.H.
        • Grundy S.M.
        • et al.
        Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.
        Circulation. 2009; 120: 1640-1645
        • Gong H.P.
        • Tan H.W.
        • Fang N.N.
        • et al.
        Impaired left ventricular systolic and diastolic function in patients with metabolic syndrome as assessed by strain and strain rate imaging.
        Diabetes Res Clin Pract. 2009; 83: 300-307
        • Seo J.M.
        • Park T.H.
        • Lee D.Y.
        • et al.
        Subclinical myocardial dysfunction in metabolic syndrome patients without hypertension.
        J Cardiovasc Ultrasound. 2011; 19: 134-139
        • Sengupta P.P.
        • Korinek J.
        • Belohlavek M.
        • et al.
        Left ventricular structure and function: basic science for cardiac imaging.
        J Am Coll Cardiol. 2006; 48: 1988-2001
        • Korosoglou G.
        • Humpert P.M.
        • Halbgewachs E.
        • et al.
        Evidence of left ventricular contractile asynchrony by echocardiographic phase imaging in patients with type 2 diabetes mellitus and without clinically evident heart disease.
        Am J Cardiol. 2006; 98: 1525-1530
        • Li S.H.
        • Yang B.
        • Gong H.P.
        • et al.
        Impaired left ventricular synchronicity in patients with metabolic syndrome, regardless of hypertension.
        J Hypertens. 2009; 27: 869-875
        • Dutheil F.
        • Lac G.
        • Lesourd B.
        • et al.
        Different modalities of exercise to reduce visceral fat mass and cardiovascular risk in metabolic syndrome: the RESOLVE* randomized trial.
        Int J Cardiol. 2013; 168: 3634-3642
        • Lorenzo C.
        • Okoloise M.
        • Williams K.
        • et al.
        The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study.
        Diabetes Care. 2003; 26: 3153-3159
        • Martinez D.A.
        • Guhl D.J.
        • Stanley W.C.
        • Vailas A.C.
        Extracellular matrix maturation in the left ventricle of normal and diabetic swine.
        Diabetes Res Clin Pract. 2003; 59: 1-9
        • Cittadini A.
        • Mantzoros C.S.
        • Hampton T.G.
        • et al.
        Cardiovascular abnormalities in transgenic mice with reduced brown fat: an animal model of human obesity.
        Circulation. 1999; 100: 2177-2183
        • Tigen K.
        • Karaahmet T.
        • Kirma C.
        • et al.
        Diffuse late gadolinium enhancement by cardiovascular magnetic resonance predicts significant intraventricular systolic dyssynchrony in patients with non-ischemic dilated cardiomyopathy.
        J Am Soc Echocardiogr. 2010; 23: 416-422
        • Clark R.J.
        • McDonough P.M.
        • Swanson E.
        • et al.
        Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation.
        J Biol Chem. 2003; 278: 44230-44237